Wyeth Settles Patent Suit Over Generic Effexor

Law360, New York (June 20, 2011, 6:57 PM EDT) -- Pfizer Inc. unit Wyeth LLC on Monday resolved its New York patent infringement lawsuit against Intellipharmaceutics International Inc. over the company’s bid to market a generic version of Wyeth's blockbuster depression and anxiety drug Effexor XR.

U.S. District Judge Laura Taylor Swain signed off on a stipulation of dismissal and a consent judgment disposing of all claims and counterclaims in the suit Wyeth launched in response to Intellipharmaceutics filing for regulatory approval to produce its own version of Effexor.

The settlement is the latest in a...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.